Schering-Plough

Contact
schering-plough.ca
+1514-426-7300

Schering-Plough Canada Inc.

16750, route Transcanadienne
H9H 4M7 Kirkland
Canada
+1514-426-7300
schering-plough.ca
Contact
Profile News
Contact

About Schering-Plough

Schering-Plough Canada has been active in Quebec since 1927. Its Pointe-Claire plant has in operation since 1962, with expansions occurring in 1969, 1974, 1999, 2002 and 2003. The new head office was opened in 2007.

Schering-Plough Canada employs more than 1000 people in Canada and is the Canadian division of Schering-Plough Corporation.

Read more about Schering-Plough
Facts about Schering-Plough
  • Industry : Pharma

News about Schering-Plough

Schering-Plough

05-Nov-2009 | business & finance

New Merck begins operations

Merck & Co., Inc. outlined its global plans following the completion of Merck's merger with Schering-Plough Corporation. The new Merck is a global health ...

Read news
Schering-Plough

16-Oct-2009 | research and development

Nobilon advances intranasal seasonal influenza vaccine into proof of concept study

Nobilon, the human vaccine business unit of Schering-Plough Corporation, announced that it has initiated a clinical Proof of Concept trial with SCH 900795 ...

Read news
Schering-Plough

07-Oct-2009 | manufacturing

Schering-Plough Canada announces a $30.7 million expansion of its production plant in Pointe-Claire

Schering-Plough Canada announced it will invest over $30 million to expand its Pointe-Claire production plant. The expansion of the plant, which currently ...

Read news
Schering-Plough

25-Sep-2009 | business & finance

Galapagos announces expanded drug discovery collaboration with Schering-Plough

Galapagos NV announced that its service division, BioFocus DPI, has initiated a drug discovery collaboration with Schering-Plough Research Institute (SPRI ...

Read news
Schering-Plough

03-Aug-2009 | business & finance

Sanofi-aventis to Acquire Merck's Interest in Merial

Sanofi-aventis and Merck & Co., Inc. announced that the companies have signed a definitive agreement under which Merck will sell its 50 percent interest ...

Read news
Schering-Plough

17-Jun-2009 | business & finance

MorphoSys Announces Extension of Antibody Alliance with Schering-Plough

MorphoSys AG announced that Schering-Plough Corporation has triggered its pre-existing option to extend the current collaboration between the two ...

Read news
Schering-Plough

22-May-2009 | business & finance

Novartis restructures of global collaboration with Schering-Plough for fixed-dose combination respiratory therapies

Novartis assumes exclusive worldwide development and marketing rights for investigational once-daily QMF149 being developed for COPD and asthma

Read news
Schering-Plough

16-Mar-2009 | research and development

Nobilon advances first vaccine into human trials

Intranasal influenza vaccine begins Phase I clinical development

Read news
Show more news about Schering-Plough

Here you will find Schering-Plough Canada Inc.